254 - Nibs and mAbs: Biologicals-Associated Infectious Complications and Mitigating Risk of Infections

Saturday, October 14, 2023

1:45 PM – 3:00 PM US ET

Location: Ballroom (Third Floor)

All relevant financial disclosures have been mitigated.

Moderator(s)

Sarah Parker, MD

Professor of Pediatric Infectious Diseases
Pediatrics
University of Colorado/Children's Hospital Colorado
Aurora, CO, United States
William Otto, MD, MSCE

Assistant Professor
Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States

Disclosure(s):

Sarah K. Parker, MD: Pfizer: Grant/Research Support (Ongoing)

William R. Otto, MD, MSCE: Moderna: Grant/Research Support ()

Co-organized by PIDS Transplant ID

At the conclusion of this session, participants will be able to:

describe the uses of immune modulators for non-oncologic conditions, their targets and potential infectious complications;
explain the physiology and clinical presentation of immune reconstitution following CAR-T and anticipated infectious complications;
describe infectious complications associated with immune checkpoint inhibitors;
identify strategies for preventing infections in patients receiving CAR-T, ICIs, or mAbs

1:45 PM – 2:10 PM US ET

Buckle Up: Managing Infectious Complications and Infection Mimickers in CAR-T Therapy for Cancer
Speaker: Pratik A. Patel, MD (he/him/his) – Emory University School of Medicine
2:10 PM – 2:35 PM US ET

Check This: Checking In on the Infectious Complications and Confounders of Immune Checkpoint Inhibitors
Speaker: Michael D. Green, MD, MPH (he/him/his) – University of Pittsburgh School of Medicine
2:35 PM – 3:00 PM US ET

Immunomodulators for Inflammatory Processes: Understanding the Targets and Potential Infectious Complications
Speaker: Sharon F. Chen, MD (she/her/hers) – Stanford University Medical Center